Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5502 Target Snapshot

Modulator of drug activity A · SINGLE PROTEIN · Escherichia coli O157:H7

33Compounds
3Assays
0Approved Drugs
17.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q8X6S1. Use UniProt Q8X6S1 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q8X6S1 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Modulator of drug activity A as ChEMBL target CHEMBL5502, mapped to UniProt Q8X6S1. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Modulator of drug activity A
SINGLE PROTEIN · Escherichia coli O157:H7
As of 2026-09-14
ChEMBL target ID
CHEMBL5502
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q8X6S1
Oxygen-insensitive NADPH nitroreductase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Modulator of drug activity A is the right protein anchor across sources, using UniProt Q8X6S1 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelOxygen-insensitive NADPH nitroreductase
UniProt AccessionQ8X6S1
Component TypeProtein
Sequence Length240 aa

Oxygen-insensitive NADPH nitroreductase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Modulator of drug activity A, mapped to UniProt Q8X6S1. ChEMBL maps the protein component as Oxygen-insensitive NADPH nitroreductase. Sequence length is 240 aa.

Mapped IDQ8X6S1
Review nameModulator of drug activity A
OrganismEscherichia coli O157:H7
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC5017.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL23065 7.0 IC50 100.0 Preclinical
CHEMBL22592 6.72 IC50 190.0 Preclinical
CHEMBL23216 6.64 IC50 230.0 Preclinical
CHEMBL23612 6.6 IC50 250.0 Preclinical
CHEMBL23330 6.05 IC50 890.0 Clinical
CHEMBL23355 5.72 IC50 1900.0 Preclinical
CHEMBL23558 5.47 IC50 3400.0 Preclinical
CHEMBL23938 5.4 IC50 4000.0 Preclinical
CHEMBL22728 5.12 IC50 7500.0 Preclinical
CHEMBL23066 5.03 IC50 9300.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
1
5.5
1
6.0
3
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

3
Total Assays
16
Tested Compounds
1
Assay Types
Functional — 3 assays, 16 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 16 5.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine